HEPAROSAN SACCHARIDES FOR THE TREATMENT OF INFLAMMATORY SKIN DISEASES
This invention relates to glycosaminoglycan (GAGs) polysaccharides, and oligosaccharides derived from GAGs, suitably sulphated heparosan saccharide wherein the SO3- / COO- ratio of the sulphated heparosan is in the range 1 to 3.8, which have been determined to inhibit keratinocyte inflammatory activ...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | BAVINGTON, CHARLES DANIEL MOSS, CLAIRE |
| description | This invention relates to glycosaminoglycan (GAGs) polysaccharides, and oligosaccharides derived from GAGs, suitably sulphated heparosan saccharide wherein the SO3- / COO- ratio of the sulphated heparosan is in the range 1 to 3.8, which have been determined to inhibit keratinocyte inflammatory activation, for use in the treatment of inflammatory disorders of the skin, in particular psoriasis, eczema and atopic dermatitis.
La présente invention concerne des polysaccharides glycosaminoglycanne (GAG), et des oligosaccharides dérivés des GAG, un saccharide de l'héparosane sulfaté de manière appropriée dans lequel le rapport SO3-/COO est compris entre 1 et 3,8, qui a été déterminé pour l'inhibition de l'activation inflammatoire de kératinocytes, destiné à être utilisé dans le traitement de troubles inflammatoires de la peau, en particulier le psoriasis, l'eczéma et la dermatite atopique. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2015075486A3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2015075486A3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2015075486A33</originalsourceid><addsrcrecordid>eNqNyrEKwjAQANAsDqL-w4GzUK2trkd6IUGTyN2BOJUicRIt1P_HxQ9wesubG_J0Qc6CCQSt9cihIwGXGdQTKBNqpKSQHYTkzhgjauYbyCkk6IIQCsnSzB7DcyqrnwuzdqTWb8r47ss0DvfyKp_-mnfVtqkOzf7YYl3_t744XC0R</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>HEPAROSAN SACCHARIDES FOR THE TREATMENT OF INFLAMMATORY SKIN DISEASES</title><source>esp@cenet</source><creator>BAVINGTON, CHARLES DANIEL ; MOSS, CLAIRE</creator><creatorcontrib>BAVINGTON, CHARLES DANIEL ; MOSS, CLAIRE</creatorcontrib><description>This invention relates to glycosaminoglycan (GAGs) polysaccharides, and oligosaccharides derived from GAGs, suitably sulphated heparosan saccharide wherein the SO3- / COO- ratio of the sulphated heparosan is in the range 1 to 3.8, which have been determined to inhibit keratinocyte inflammatory activation, for use in the treatment of inflammatory disorders of the skin, in particular psoriasis, eczema and atopic dermatitis.
La présente invention concerne des polysaccharides glycosaminoglycanne (GAG), et des oligosaccharides dérivés des GAG, un saccharide de l'héparosane sulfaté de manière appropriée dans lequel le rapport SO3-/COO est compris entre 1 et 3,8, qui a été déterminé pour l'inhibition de l'activation inflammatoire de kératinocytes, destiné à être utilisé dans le traitement de troubles inflammatoires de la peau, en particulier le psoriasis, l'eczéma et la dermatite atopique.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150903&DB=EPODOC&CC=WO&NR=2015075486A3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150903&DB=EPODOC&CC=WO&NR=2015075486A3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BAVINGTON, CHARLES DANIEL</creatorcontrib><creatorcontrib>MOSS, CLAIRE</creatorcontrib><title>HEPAROSAN SACCHARIDES FOR THE TREATMENT OF INFLAMMATORY SKIN DISEASES</title><description>This invention relates to glycosaminoglycan (GAGs) polysaccharides, and oligosaccharides derived from GAGs, suitably sulphated heparosan saccharide wherein the SO3- / COO- ratio of the sulphated heparosan is in the range 1 to 3.8, which have been determined to inhibit keratinocyte inflammatory activation, for use in the treatment of inflammatory disorders of the skin, in particular psoriasis, eczema and atopic dermatitis.
La présente invention concerne des polysaccharides glycosaminoglycanne (GAG), et des oligosaccharides dérivés des GAG, un saccharide de l'héparosane sulfaté de manière appropriée dans lequel le rapport SO3-/COO est compris entre 1 et 3,8, qui a été déterminé pour l'inhibition de l'activation inflammatoire de kératinocytes, destiné à être utilisé dans le traitement de troubles inflammatoires de la peau, en particulier le psoriasis, l'eczéma et la dermatite atopique.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyrEKwjAQANAsDqL-w4GzUK2trkd6IUGTyN2BOJUicRIt1P_HxQ9wesubG_J0Qc6CCQSt9cihIwGXGdQTKBNqpKSQHYTkzhgjauYbyCkk6IIQCsnSzB7DcyqrnwuzdqTWb8r47ss0DvfyKp_-mnfVtqkOzf7YYl3_t744XC0R</recordid><startdate>20150903</startdate><enddate>20150903</enddate><creator>BAVINGTON, CHARLES DANIEL</creator><creator>MOSS, CLAIRE</creator><scope>EVB</scope></search><sort><creationdate>20150903</creationdate><title>HEPAROSAN SACCHARIDES FOR THE TREATMENT OF INFLAMMATORY SKIN DISEASES</title><author>BAVINGTON, CHARLES DANIEL ; MOSS, CLAIRE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2015075486A33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2015</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BAVINGTON, CHARLES DANIEL</creatorcontrib><creatorcontrib>MOSS, CLAIRE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BAVINGTON, CHARLES DANIEL</au><au>MOSS, CLAIRE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>HEPAROSAN SACCHARIDES FOR THE TREATMENT OF INFLAMMATORY SKIN DISEASES</title><date>2015-09-03</date><risdate>2015</risdate><abstract>This invention relates to glycosaminoglycan (GAGs) polysaccharides, and oligosaccharides derived from GAGs, suitably sulphated heparosan saccharide wherein the SO3- / COO- ratio of the sulphated heparosan is in the range 1 to 3.8, which have been determined to inhibit keratinocyte inflammatory activation, for use in the treatment of inflammatory disorders of the skin, in particular psoriasis, eczema and atopic dermatitis.
La présente invention concerne des polysaccharides glycosaminoglycanne (GAG), et des oligosaccharides dérivés des GAG, un saccharide de l'héparosane sulfaté de manière appropriée dans lequel le rapport SO3-/COO est compris entre 1 et 3,8, qui a été déterminé pour l'inhibition de l'activation inflammatoire de kératinocytes, destiné à être utilisé dans le traitement de troubles inflammatoires de la peau, en particulier le psoriasis, l'eczéma et la dermatite atopique.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2015075486A3 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | HEPAROSAN SACCHARIDES FOR THE TREATMENT OF INFLAMMATORY SKIN DISEASES |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T01%3A20%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BAVINGTON,%20CHARLES%20DANIEL&rft.date=2015-09-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2015075486A3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |